Severe Asthma Research Recap: 8 Updates for Primary Care

Research summaries on GINA revisions, a steroid-reduction algorithm, factors that predict asthma exacerbation risk, and more.

Global Initiative for Asthma (GINA) treatment divided into tracks, greater precision in exacerbation risk prediction, an individualized algorithm to reduce steroids, and reasons why patients don't adhere to treatment—these are some of the more significant recent developments in severe asthma research.

Scroll through the slides below for concise summaries of the latest findings.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
© 2023 MJH Life Sciences

All rights reserved.